![logo](/logos/CODX.webp)
Co-Diagnostics, Inc.
NASDAQ:CODX
1.34 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Co-Diagnostics, Inc. |
Symbool | CODX |
Munteenheid | USD |
Prijs | 1.34 |
Beurswaarde | 42,760,740 |
Dividendpercentage | 0% |
52-weken bereik | 0.981 - 2.23 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Mr. Dwight H. Egan |
Website | https://www.codiagnostics.com |
An error occurred while fetching data.
Over Co-Diagnostics, Inc.
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)